by Maria Zannes | Mar 6, 2023 | Articles, News
MARCH 6, 2023 The Empowered Patient podcast host Karen Jagoda recently interviewed bioAffinity Technologies President and CEO Maria Zannes about the development of the CyPath® Lung test for the detection of early-stage lung cancer. Hear the podcast at...
by Maria Zannes | Feb 22, 2023 | Articles, News
FEBRUARY 22, 2023 bioAffinity Technologies President and CEO Maria Zannes recently joined host Seth Farbman on his podcast From Start-Up to Stock Exchange. Listen here https://lnkd.in/g-vkTfKv to learn more about the need for early screening for lung cancer when it is...
by Maria Zannes | Dec 28, 2022 | Articles, News
Meet BioAffinity Technologies: Fly exclusive interview with CEO Maria Zannes DECEMBER 28, 2022 As published in the The Fly By: Jessica de Sa-Mota BioAffinity focuses on the development of noninvasive, early-stage cancer diagnosis and targeted cancer treatment In an...
by Maria Zannes | Dec 23, 2022 | Articles, News
SA Cancer Diagnostic Company Adding Research Talent DECEMBER 23, 2022 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal BioAffinity Technologies Inc. is making multiple personnel moves in an effort to...
by Maria Zannes | Dec 21, 2022 | Articles, News
TEXAS 100 Influential professionals to watch in 2023 DECEMBER 21, 2022 As published in the San Antonio Business Journal By: Colin Pope – Editor, Austin Business Journal Our annual Texas 100 is a list of impactful Texans who will likely play crucial roles in the...
by Maria Zannes | Nov 29, 2022 | Articles, News
After going public, SA company charts next course NOVEMBER 29, 2022 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San Antonio Business Journal Fresh off of filing its first earnings report as a publicly traded company, San...
